Analysis reveals increased relapse and metastasis risk linked to immune-inflammation index in older cervical cancer patients, suggesting clinical significance.
Higher levels of SII are significantly associated with a higher risk of relapse and metastasis, indicating that SII may have important clinical value in the prognosis assessment of CSCC.
No takes yet. Share an insight, caveat, or question.
Jiao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from BMC Immunology